你即將離開本站

並前往https://www.keionline.org/zolgensma

Zolgensma - Knowledge Ecology International

Zolgensma is a gene therapy for spinal muscular atrophy (SMA) that was approved by the US FDA in May 2019, at a price of $2.1 million per patient.

確定！ 回上一頁

查詢 「Zolgensma FDA」的人也找了：

  1. Zolgensma
    2.
  2. START zolgensma
    3.
  3. FDA approved CAR T
    4.
  4. Zolgensma label
    5.
  5. Zolgensma price
    6.
  6. Zolgensma Novartis
    7.
  7. Zolgensma Mechanism
    8.
  8. FDA-approved stem cell therapy
    9.